Enterprise Value
1.192M
Cash
29.22M
Avg Qtr Burn
-7.704M
Short % of Float
0.30%
Insider Ownership
33.03%
Institutional Own.
16.37%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ELI-002 Details Pancreatic cancer, Cancer | Phase 1 Data readout | |
ANG-3777 (HGF mimetic) Details Acute respiratory distress syndrome | Failed Discontinued | |
ANG-3070 (TKI) Details Focal segmental glomerulosclerosis, IgA nephropathy | Failed Discontinued | |
ANG-3777 (HGF mimetic) Details Acute Kidney Injury | Failed Discontinued | |
ANG-3777 (HGF mimetic) Details Acute Kidney Injury | Failed Discontinued |